BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 29171320)

  • 1. The role of mitochondrial folate enzyme MTHFD1L in esophageal squamous cell carcinoma.
    Yang YS; Yuan Y; Hu WP; Shang QX; Chen LQ
    Scand J Gastroenterol; 2018 May; 53(5):533-540. PubMed ID: 29171320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knockdown of DDX46 inhibits proliferation and induces apoptosis in esophageal squamous cell carcinoma cells.
    Li B; Li YM; He WT; Chen H; Zhu HW; Liu T; Zhang JH; Song TN; Zhou YL
    Oncol Rep; 2016 Jul; 36(1):223-30. PubMed ID: 27176873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MTHFD1L as a folate cycle enzyme correlates with prognostic outcome and its knockdown impairs cell invasive behaviors in osteosarcoma via mediating the AKT/mTOR pathway.
    Wang L; Yang Y; Wang XM; Wang CQ; Zhang YM; Li BL
    J Recept Signal Transduct Res; 2020 Dec; 40(6):584-590. PubMed ID: 32456526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long noncoding RNA, tissue differentiation-inducing nonprotein coding RNA is upregulated and promotes development of esophageal squamous cell carcinoma.
    Xu Y; Qiu M; Chen Y; Wang J; Xia W; Mao Q; Yang L; Li M; Jiang F; Xu L; Yin R
    Dis Esophagus; 2016 Nov; 29(8):950-958. PubMed ID: 26833746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deletion of the neural tube defect-associated gene
    Bryant JD; Sweeney SR; Sentandreu E; Shin M; Ipas H; Xhemalce B; Momb J; Tiziani S; Appling DR
    J Biol Chem; 2018 Apr; 293(16):5821-5833. PubMed ID: 29483189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folate cycle enzyme MTHFD1L confers metabolic advantages in hepatocellular carcinoma.
    Lee D; Xu IM; Chiu DK; Lai RK; Tse AP; Lan Li L; Law CT; Tsang FH; Wei LL; Chan CY; Wong CM; Ng IO; Wong CC
    J Clin Invest; 2017 May; 127(5):1856-1872. PubMed ID: 28394261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear Localization of DNAJB6 Is Associated With Survival of Patients With Esophageal Cancer and Reduces AKT Signaling and Proliferation of Cancer Cells.
    Yu VZ; Wong VC; Dai W; Ko JM; Lam AK; Chan KW; Samant RS; Lung HL; Shuen WH; Law S; Chan YP; Lee NP; Tong DK; Law TT; Lee VH; Lung ML
    Gastroenterology; 2015 Dec; 149(7):1825-1836.e5. PubMed ID: 26302489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR‑378a‑3p exerts tumor suppressive function on the tumorigenesis of esophageal squamous cell carcinoma by targeting Rab10.
    Ding N; Sun X; Wang T; Huang L; Wen J; Zhou Y
    Int J Mol Med; 2018 Jul; 42(1):381-391. PubMed ID: 29693138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Musashi1, a potential prognostic marker in esophageal squamous cell carcinoma.
    Qin G; Lian J; Yue D; Chen X; Nan S; Qi Y; Li B; Cui G; Li X; Zhao S; Zhang Y
    Oncol Rep; 2017 Sep; 38(3):1724-1732. PubMed ID: 28713964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deletion of neural tube defect-associated gene Mthfd1l causes reduced cranial mesenchyme density.
    Shin M; Vaughn A; Momb J; Appling DR
    Birth Defects Res; 2019 Nov; 111(19):1520-1534. PubMed ID: 31518072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNF113A promotes the proliferation, migration and invasion, and is associated with a poor prognosis of esophageal squamous cell carcinoma.
    Wang L; Hou Z; Hasim A; Abuduerheman A; Zhang H; Niyaz M; Awut I; Upur H; Sheyhidin I
    Int J Oncol; 2018 Mar; 52(3):861-871. PubMed ID: 29393393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melatonin modulates metabolic remodeling in HNSCC by suppressing MTHFD1L-formate axis.
    Cui L; Zhao X; Jin Z; Wang H; Yang SF; Hu S
    J Pineal Res; 2021 Dec; 71(4):e12767. PubMed ID: 34533844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of SALL4 reduces tumorigenicity involving epithelial-mesenchymal transition via Wnt/β-catenin pathway in esophageal squamous cell carcinoma.
    He J; Zhou M; Chen X; Yue D; Yang L; Qin G; Zhang Z; Gao Q; Wang D; Zhang C; Huang L; Wang L; Zhang B; Yu J; Zhang Y
    J Exp Clin Cancer Res; 2016 Jun; 35(1):98. PubMed ID: 27329034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial C1-tetrahydrofolate synthase (MTHFD1L) supports the flow of mitochondrial one-carbon units into the methyl cycle in embryos.
    Pike ST; Rajendra R; Artzt K; Appling DR
    J Biol Chem; 2010 Feb; 285(7):4612-20. PubMed ID: 19948730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long noncoding RNA H19 is up-regulated in esophageal squamous cell carcinoma and promotes cell proliferation and metastasis.
    Tan D; Wu Y; Hu L; He P; Xiong G; Bai Y; Yang K
    Dis Esophagus; 2017 Jan; 30(1):1-9. PubMed ID: 27247022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles of phosphorylated JNK in esophageal squamous cell carcinomas of Kazakh ethnic.
    Qin X; Zheng S; Liu T; Liu Q; Liang M; Li X; Sheyhidin I; Lu X
    Mol Carcinog; 2014 Jul; 53(7):526-36. PubMed ID: 23359384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. lncRNA UCA1 inhibits esophageal squamous-cell carcinoma growth by regulating the Wnt signaling pathway.
    Wang X; Gao Z; Liao J; Shang M; Li X; Yin L; Pu Y; Liu R
    J Toxicol Environ Health A; 2016; 79(9-10):407-18. PubMed ID: 27267823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TDO2 Overexpression Is Associated with Cancer Stem Cells and Poor Prognosis in Esophageal Squamous Cell Carcinoma.
    Pham QT; Oue N; Sekino Y; Yamamoto Y; Shigematsu Y; Sakamoto N; Sentani K; Uraoka N; Yasui W
    Oncology; 2018; 95(5):297-308. PubMed ID: 30134247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MTHFD1L confers a poor prognosis and malignant phenotype in esophageal squamous cell carcinoma by activating the ERK5 signaling pathway.
    Zhou J; Yang Y; Cheng J; Luan S; Xiao X; Li X; Fang P; Gu Y; Shang Q; Zhang H; Chen L; Zeng X; Yuan Y
    Exp Cell Res; 2023 Jun; 427(1):113584. PubMed ID: 37004948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Up-regulation of lncRNA CASC9 promotes esophageal squamous cell carcinoma growth by negatively regulating PDCD4 expression through EZH2.
    Wu Y; Hu L; Liang Y; Li J; Wang K; Chen X; Meng H; Guan X; Yang K; Bai Y
    Mol Cancer; 2017 Aug; 16(1):150. PubMed ID: 28854977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.